Suppr超能文献

2D Fe/Co-MOF/SOX 级联反应器用于快速无创检测前列腺癌尿液中的肌氨酸水平。

2D Fe/Co-MOF/SOX cascade reactors for fast noninvasive detection of sarcosine level in prostate cancer urine.

机构信息

Institute of Polymer Science and Engineering, Hebei University of Technology, 5340 Siping Road, Tianjin 300401, China.

The Second Hospital of Tianjin Medical University, Tianjin Key Laboratory of Precision Medicine for Sex Hormones and Diseases (in Preparation), Tianjin 300211, China.

出版信息

J Colloid Interface Sci. 2025 Feb;679(Pt B):401-411. doi: 10.1016/j.jcis.2024.10.111. Epub 2024 Oct 22.

Abstract

Sarcosine plays a key role in screening for early prostate cancer. However, the several already reported peroxidase mimics immobilized with sarcosine oxidase (SOX) utilized to detect uriary sarcosine still have some limitations such as complex synthesis process, using of expensive heavy metals to mimic enzyme activity and long color development time. Herein, an inexpensive peroxidase-like 2D Fe/Co-MOF nanosheet was prepared by a simple solvent modulation method. The resultant 2D Fe/Co-MOF nanosheets have strong peroxidase activity, with its Vmax value for HO of 15.3 × 10 M/s, being 1.76 times that of HRP. Then, using the 2D Fe/Co-MOF as a peroxidase model for anchoring natural SOX to construct 2D Fe/Co-MOF/SOX , which can act as a cascade reactor for detection of sarcosine. Considering the above properties, a platform for the detection of sarcosine was built based on a colorimetric method. Because of presence of the high ratio of Fe caused by the electron transfer from Co to Fe, large specific surface area and plentiful active sites, 2D Fe/Co-MOF/SOX with TMB (3,3',5,5'-tetramethylbenzidine) colorimetric reagent could have fast color development and can be applied conveniently and fastly in an early screening tool for prostate cancer patients. The sarcosine could be quantified by peroxidase activity with a detection range of 1-400 μM and a limit of detection (LOD) of 0.324 μM. More importantly, the average sarcosine concentration of 21.367 μM and 1.871 μM was detected in patient's and normal urine (n = 5), respectively, which showed an excellent screening effect and a great potential in early prostate cancer.

摘要

肌氨酸在早期前列腺癌筛查中起着关键作用。然而,已经报道的几种利用肌氨酸氧化酶(SOX)固定化的过氧化物模拟酶来检测尿液中的肌氨酸仍然存在一些局限性,例如合成过程复杂、使用昂贵的重金属来模拟酶活性以及显色时间长。在此,通过简单的溶剂调制方法制备了一种廉价的类过氧化物酶二维 Fe/Co-MOF 纳米片。所得二维 Fe/Co-MOF 纳米片具有很强的过氧化物酶活性,其 HO 的 Vmax 值为 15.3×10 M/s,是 HRP 的 1.76 倍。然后,将二维 Fe/Co-MOF 用作过氧化物酶模型来固定天然 SOX 以构建二维 Fe/Co-MOF/SOX,它可以作为检测肌氨酸的级联反应器。考虑到上述特性,基于比色法构建了肌氨酸检测平台。由于 Co 向 Fe 的电子转移导致 Fe 的比例较高、比表面积大且有丰富的活性位点,因此具有 TMB(3,3',5,5'-四甲基联苯胺)比色试剂的二维 Fe/Co-MOF/SOX 具有快速显色的特点,并且可以方便快速地应用于前列腺癌患者的早期筛查工具。通过过氧化物酶活性可以定量检测肌氨酸,检测范围为 1-400 μM,检测限(LOD)为 0.324 μM。更重要的是,在患者和正常人尿液中分别检测到平均肌氨酸浓度为 21.367 μM 和 1.871 μM(n=5),显示出极好的筛选效果和在早期前列腺癌中的巨大潜力。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验